"Drugs Don't Work in Patients Who Don't Take Them".
Sign Up to like & getrecommendations! Published in 2019 at "Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie"
DOI: 10.1024/1422-4917/a000645
Abstract: The more recent term "adherence" is now taking the place of the earlier notion of "compliance," as it emphasizes the physician-patient partnership. To date, however, it has not been clearly defined. There are many limitations… read more here.
Keywords: medicine; patients take; work patients; drugs work ... See more keywords
Learned lessons from patients who take clozapine: A case study.
Sign Up to like & getrecommendations! Published in 2018 at "Perspectives in psychiatric care"
DOI: 10.1111/ppc.12245
Abstract: PURPOSE The purpose of this report is to provide clinical strategies to manage patients with schizophrenia taking clozapine. CONCLUSIONS Serious side effects and required blood monitoring impede the use of clozapine, despite the benefits of… read more here.
Keywords: take clozapine; clozapine case; patients take; learned lessons ... See more keywords
Should we be concerned when COVID-19-positive patients take opioids to control their pain? Insights from a pharmacological point of view.
Sign Up to like & getrecommendations! Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202107_26399
Abstract: OBJECTIVE The purpose of this narrative review is to discuss the available information regarding the currently utilized COVID-19 therapies (and the evidence level supporting them) and opioids for chronic pain with a focus on warnings… read more here.
Keywords: covid positive; take opioids; opioids control; concerned covid ... See more keywords
Comparison of serum levels of asymmetric dimethylarginine between patients who take two types of atypical anti psychotics
Sign Up to like & getrecommendations! Published in 2019 at "Medical Journal of The Islamic Republic of Iran"
DOI: 10.47176/mjiri.33.114
Abstract: Background: Schizophrenia is associated with increased cardiovascular morbidity. Asymmetric dimethylarginine (ADMA) has been suggested as a cardiovascular biomarker. Treatment with atypical antipsychotics can increase some traditional risk factors of coronary artery disease. In addition to… read more here.
Keywords: comparison serum; traditional factors; patients take; non traditional ... See more keywords